Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei Ding

Showing results (1-10 of 2,056) with videos related to

Pageof 206
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2018
Richter transformation in the era of novel agentsWei Ding
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|January 29, 2005
[A histone deacetylase inhibitor and tumor suppressing gene p53 induction synergistically induce apoptosis of cancer cells]Wei Ding
Hematology/Oncology Clinics of North America|June 27, 2021
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and BeyondWei Ding
Computational Intelligence and Neuroscience|June 9, 2022
Ink Animation VR Design Based on Wireless Sensor and HTML5 Interactive TechnologyWei Ding
Journal of Environmental Management|January 23, 2022
Bridging-induced densification strategy based on biomass-derived aldehyde tanning integrated with terminal Al(III) crosslinking towards high-performance chrome-free leather productionWei Ding
Current Opinion in Virology|November 27, 2018
Editorial overview: Engineering for viral resistanceShou-Wei Ding
Nature Reviews. Immunology|August 14, 2010
RNA-based antiviral immunityShou-Wei Ding
Phytopathology|November 28, 2022
Transgene Silencing, RNA Interference, and the Antiviral Defense Mechanism Directed by Small Interfering RNAsShou-Wei Ding
Hematology. American Society of Hematology. Education Program|January 18, 2011
Evidence-based mini-review: the role of alkylating agents in the initial treatment of chronic lymphocytic leukemia patients with the 11q deletionWei Ding, Alessandra Ferrajoli
Angewandte Chemie (International Ed. in English)|January 8, 2019
Cobalt-Catalyzed Intermolecular [2+2] Cycloaddition between Alkynes and AllenesWei Ding, Naohiko Yoshikai
Pageof 206

Showing results (1-10 of 2,056) with videos related to

Sort By:
Pageof 206
Hematology. American Society of Hematology. Education Program|December 4, 2018
Richter transformation in the era of novel agentsWei Ding
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|January 29, 2005
[A histone deacetylase inhibitor and tumor suppressing gene p53 induction synergistically induce apoptosis of cancer cells]Wei Ding
Hematology/Oncology Clinics of North America|June 27, 2021
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and BeyondWei Ding
Computational Intelligence and Neuroscience|June 9, 2022
Ink Animation VR Design Based on Wireless Sensor and HTML5 Interactive TechnologyWei Ding
Journal of Environmental Management|January 23, 2022
Bridging-induced densification strategy based on biomass-derived aldehyde tanning integrated with terminal Al(III) crosslinking towards high-performance chrome-free leather productionWei Ding
Current Opinion in Virology|November 27, 2018
Editorial overview: Engineering for viral resistanceShou-Wei Ding
Nature Reviews. Immunology|August 14, 2010
RNA-based antiviral immunityShou-Wei Ding
Phytopathology|November 28, 2022
Transgene Silencing, RNA Interference, and the Antiviral Defense Mechanism Directed by Small Interfering RNAsShou-Wei Ding
Hematology. American Society of Hematology. Education Program|January 18, 2011
Evidence-based mini-review: the role of alkylating agents in the initial treatment of chronic lymphocytic leukemia patients with the 11q deletionWei Ding, Alessandra Ferrajoli
Angewandte Chemie (International Ed. in English)|January 8, 2019
Cobalt-Catalyzed Intermolecular [2+2] Cycloaddition between Alkynes and AllenesWei Ding, Naohiko Yoshikai
Pageof 206